Quotes 5-day view Delayed London Stock Exchange
10/18/2021
10/19/2021
10/20/2021
10/21/2021
10/22/2021
Date
1395.6(c)
1407.2(c)
1408.2(c)
1410.8(c)
1420.8(c)
Last
3 999 834
5 486 304
5 270 230
4 433 757
4 294 791
Volume
-0.29% +0.83% +0.07% +0.18% +0.71% Change
Estimated financial data (e) GBP USD
Sales 2021
33 519 M 46 092 M 46 092 M
Net income 2021
3 787 M 5 207 M 5 207 M
Net Debt 2021
21 074 M 28 978 M 28 978 M
P/E ratio 2021
18,6x
Yield 2021
5,63%
Sales 2022
35 229 M 48 443 M 48 443 M
Net income 2022
4 589 M 6 311 M 6 311 M
Net Debt 2022
19 680 M 27 062 M 27 062 M
P/E ratio 2022
15,6x
Yield 2022
3,87%
Capitalization
71 110 M 97 886 M 97 784 M
EV / Sales 2021
2,75x
EV / Sales 2022
2,58x
Nbr of Employees
94 066
Free-Float
92,3%
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business...
Ratings of GlaxoSmithKline plc
All news about GLAXOSMITHKLINE PLC
10/21 GLAXOSMITHKLINE : Says CDC Panel Voted to Recommend Approval of Shingles Vaccine CandidateMT
10/20 GLAXOSMITHKLINE : Shingles Vaccine Receives Recommendation in US for Immunocompromised Adu..MT
10/20 Glaxosmithkline plc Announces Unanimous Votes of US Centers for Disease Control and Pre.. CI
10/20 GLAXOSMITHKLINE : US Centers for Disease Control and Prevention's Advisory Committee on Im..PU
10/20 GLAXOSMITHKLINE : Viom, GlaxoSmithKline Expand Collaboration Into New Cancer, Autoimmune D..MT
10/20 LESS TALK, MORE ACTION : New report sponsored by ViiV Healthcare provides roadmap to achie..PU
10/20 Viome Life Sciences Announces Expansion of Collaboration with GSK into New Therapeutic .. CI
10/19 'Green is good' says UK's Johnson, wooing Wall Street dollars RE
10/19 Pharnext renforce son équipe de direction avec trois nominations clés pour poursuivre l.. DJ
10/19 Pharnext strengthens its management team with three key appointments to support ongoing.. DJ
10/18 GLAXOSMITHKLINE : GSK to showcase significant scientific advances in renal care at the Ame..PU
10/18 Today on Wall Street : This is the real test10/18 GLAXOSMITHKLINE : Berenberg Slashes GlaxoSmithKline's PT, Keeps RatingMT
10/18 GLAXOSMITHKLINE : Berenberg Maintains GlaxoSmithKline At Buy, Trims PTMT
10/18 ANALYST RECOMMENDATIONS : Drax, GlaxoSmithKline, Goldman Sachs, JP Morgan, Steel Dynamics...
News in other languages on GLAXOSMITHKLINE PLC
Analyst Recommendations on GLAXOSMITHKLINE PLC
GlaxoSmithKline : GSK on track with consumer split as buyout report boosts shares
Chart GLAXOSMITHKLINE PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GLAXOSMITHKLINE PLC
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
14,21 GBX
Average target price
1 602,73 GBX
Spread / Average Target
11 180%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
